Dokumendiregister | Sotsiaalministeerium |
Viit | 1.4-2/2533-1 |
Registreeritud | 08.10.2024 |
Sünkroonitud | 09.10.2024 |
Liik | Sissetulev kiri |
Funktsioon | 1.4 EL otsustusprotsess ja rahvusvaheline koostöö |
Sari | 1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik) |
Toimik | 1.4-2/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | Eesti Vabariigi Alaline Esindus EL juures |
Saabumis/saatmisviis | Eesti Vabariigi Alaline Esindus EL juures |
Vastutaja | Tiina Rootamm (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond) |
Originaal | Ava uues aknas |
From: SANTE CONSULT B2 <[email protected]>
Sent: Mon, 07 Oct 2024 13:36:04 +0000
To: "(MISSION OF THE PRINCIPALITY OF LIECHTENSTEIN TO THE EUROPEAN UNION)" <[email protected]>; (Permanent Representation of Austria = Représentation permanente de l'Autriche) <[email protected]>; (Permanent Representation of Belgium = Représentation permanente de la Belgique) <[email protected]>; (Permanent Representation of Bulgaria = Représentation permanente de la Bulgarie) <[email protected]>; (Permanent Representation of Croatia = Représentation permanente de la Croatie) <[email protected]>; (Permanent Representation of Cyprus = Représentation permanente de Chypre) <[email protected]>; (Permanent Representation of Denmark = Représentation permanente du Danemark) <[email protected]>; (Permanent Representation of Estonia = Représentation permanente de l'Estonie) <[email protected]>; (Permanent Representation of Finland = Représentation permanente de la Finlande) <[email protected]>; (Permanent Representation of France = Représentation permanente de la France) <[email protected]>; (Permanent Representation of Germany = Représentation permanente de l'Allemagne) <[email protected]>; (Permanent Representation of Greece = Représentation permanente de la Grèce) <[email protected]>; (Permanent Representation of Hungary = Représentation permanente de la Hongrie) <[email protected]>; "(Permanent Representation of Iceland to the European Union)" <[email protected]>; (Permanent Representation of Ireland = Représentation permanente de l'Irlande) <[email protected]>; (Permanent Representation of Italy = Représentation permanente de l'Italie = Rappresentanza Permanente d’Italia presso l’Uni... <[email protected]>; (Permanent Representation of Latvia = Représentation permanente de la Lettonie) <[email protected]>; (Permanent Representation of Lithuania = Représentation permanente de la Lituanie) <[email protected]>; (Permanent Representation of Luxembourg = Représentation permanente du Luxembourg) <[email protected]>; (Permanent Representation of Malta = Représentation permanente de Malte) <[email protected]>; (Permanent Representation of Netherlands = Représentation permanente des Pays-Bas) <[email protected]>; (Permanent Representation of Norway = Représentation permanente de la Norvège) <[email protected]>; (Permanent Representation of Poland = Représentation permanente de la Pologne) <[email protected]>; (Permanent Representation of Portugal = Représentation permanente du Portugal) <[email protected]>; (Permanent Representation of Romania = Représentation permanente de la Roumanie) <[email protected]>; (Permanent Representation of Slovakia = Représentation permanente de la Slovaquie) <[email protected]>; (Permanent Representation of Slovenia = Représentation permanente de la Slovénie) <[email protected]>; (Permanent Representation of Spain = Représentation permanente d'Espagne) <[email protected]>; (Permanent Representation of Sweden = Représentation permanente de Suède) <[email protected]>; (Permanent Representation of the Czech Republic = Représentation permanente de la République tchèque) <[email protected]>
Subject: Invitation to nominate Member State representatives to the Committee on serious cross-border threats to health (in accordance with Article 29 of Regulation (EU) 2022/2371) - Ares(2024)7084203
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË – Tel. +32 22991111
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY
Public Health, Cancer and Health security
Director
Luxembourg SANTE.B.2/YK/ed (2024)8025331
EU Permanent Representatives
Email transmission only
NOTE FOR THE ATTENTION OF THE PERMANENT REPRESENTATIONS OF THE MEMBER
STATES OF THE EUROPEAN UNION
Subject: Invitation to nominate Member State representatives to the Committee
on serious cross-border threats to health (in accordance with Article 29
of Regulation (EU) 2022/2371)
Article 15 of Regulation (EU) 2022/2371 on serious cross-border threats to health and
repealing Decision No 1082/2013/EU (1) empowers the European Commission to
designate EU reference laboratories in the area of public health or for specific areas of
public health, “to provide support to national reference laboratories to promote good
practice and alignment by Member States on a voluntary basis on diagnostics, testing
methods, use of certain tests for the uniform surveillance, notification and reporting of
diseases by Member States”.
On 22 March 2024, the European Commission adopted Implementing Regulation (EU)
2024/892, which designated the first six EU reference laboratories for certain specific areas
of public health (2). The adoption was based on the opinion of the Committee on serious
cross-border threats to health formulated in a meeting on 7 March 2024, for which you
nominated a representative from your country.
The European Commission has prepared a second Implementing Regulation, which would
designate further three EU reference laboratories in certain specific areas of public health.
The Committee on serious cross-border threats to health will again be tasked to provide an
opinion for the Commission regarding the adoption of this Implementing Regulation.
For the purpose of the above-mentioned adoption, the Committee will be convened on
Tuesday 12 November from 11:00-12:00 (CET).
(1) Regulation (EU) 2022/2371 of the European Parliament and of the Council of 23 November 2022 on
serious cross-border threats to health and repealing Decision No 1082/2013/EU (OJ L 314, 6.12.2022,
p. 26).
(2) Commission Implementing Regulation (EU) 2024/892 of 22 March 2024 designating European Union
reference laboratories for certain specific areas of public health (OJ L, 2024/892, 25.3.2024, ELI:
http://data.europa.eu/eli/reg_impl/2024/892/oj).
2
We would like to invite you to nominate a representative of your country to the
Committee on serious cross-border threats to health. Please let us know if you decide
to nominate the same representative who took part in the meeting of the Committee on
serious cross-border threats to health in March this year, and who is already familiar with
the comitology process and the topic of the EU reference laboratories.
We would be grateful to receive your nominations to the Committee on serious cross-
border threats to health by Wednesday 16 October 2024. Please send your nominations to
Antonio PARENTI
c.c.: SANTE CONSULT B2
Electronically signed on 07/10/2024 09:31 (UTC+02) in accordance with Article 11 of Commission Decision (EU) 2021/2121
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË – Tel. +32 22991111
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY
Public Health, Cancer and Health security
Director
Luxembourg SANTE.B.2/YK/ed (2024)8025331
EU Permanent Representatives
Email transmission only
NOTE FOR THE ATTENTION OF THE PERMANENT REPRESENTATIONS OF THE MEMBER
STATES OF THE EUROPEAN UNION
Subject: Invitation to nominate Member State representatives to the Committee
on serious cross-border threats to health (in accordance with Article 29
of Regulation (EU) 2022/2371)
Article 15 of Regulation (EU) 2022/2371 on serious cross-border threats to health and
repealing Decision No 1082/2013/EU (1) empowers the European Commission to
designate EU reference laboratories in the area of public health or for specific areas of
public health, “to provide support to national reference laboratories to promote good
practice and alignment by Member States on a voluntary basis on diagnostics, testing
methods, use of certain tests for the uniform surveillance, notification and reporting of
diseases by Member States”.
On 22 March 2024, the European Commission adopted Implementing Regulation (EU)
2024/892, which designated the first six EU reference laboratories for certain specific areas
of public health (2). The adoption was based on the opinion of the Committee on serious
cross-border threats to health formulated in a meeting on 7 March 2024, for which you
nominated a representative from your country.
The European Commission has prepared a second Implementing Regulation, which would
designate further three EU reference laboratories in certain specific areas of public health.
The Committee on serious cross-border threats to health will again be tasked to provide an
opinion for the Commission regarding the adoption of this Implementing Regulation.
For the purpose of the above-mentioned adoption, the Committee will be convened on
Tuesday 12 November from 11:00-12:00 (CET).
(1) Regulation (EU) 2022/2371 of the European Parliament and of the Council of 23 November 2022 on
serious cross-border threats to health and repealing Decision No 1082/2013/EU (OJ L 314, 6.12.2022,
p. 26).
(2) Commission Implementing Regulation (EU) 2024/892 of 22 March 2024 designating European Union
reference laboratories for certain specific areas of public health (OJ L, 2024/892, 25.3.2024, ELI:
http://data.europa.eu/eli/reg_impl/2024/892/oj).
2
We would like to invite you to nominate a representative of your country to the
Committee on serious cross-border threats to health. Please let us know if you decide
to nominate the same representative who took part in the meeting of the Committee on
serious cross-border threats to health in March this year, and who is already familiar with
the comitology process and the topic of the EU reference laboratories.
We would be grateful to receive your nominations to the Committee on serious cross-
border threats to health by Wednesday 16 October 2024. Please send your nominations to
Antonio PARENTI
c.c.: SANTE CONSULT B2
Electronically signed on 07/10/2024 09:31 (UTC+02) in accordance with Article 11 of Commission Decision (EU) 2021/2121
Saatja: Webdesktop <[email protected]>
Saadetud: 07.10.2024 19:15
Adressaat: <[email protected]>; <"Maret Voore">
Koopia: <"[email protected]">
Teema: Webdesktop: Esindaja nimetamine komiteesse, milles käsitletakse
tõsiseid piiriüleseid terviseohtusid
Tere!Edastan Komisjoni kirja. Vastamise tähtaeg 16.okt.EV AEEL juures
reg. number: 10.2-11/1050Reg. kuupäev: 07.10.2024Sisu: Esindaja
nimetamine komiteesse, milles käsitletakse tõsiseid piiriüleseid
terviseohtusidInvitation to nominate Member State representatives to the
Committee on serious cross-border threats to health (in accordance with
Article 29 of Regulation (EU) 2022/2371)-- Heade soovidegaTiiu
Noobelsekretär, EV alaline esindus EL juures+32 2227 4337